Todd Asset Management LLC Abb Vie Inc. Transaction History

Todd Asset Management LLC

$4.09 Billion
Q3 2024

A detailed history of Todd Asset Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Todd Asset Management LLC holds 226,796 shares of ABBV stock, worth $39.8 Million. This represents 1.1% of its overall portfolio holdings.

Number of Shares

226,796

Previous 226,968 0.08%

Holding current value

$39.8 Million

Previous $38.9 Million 15.05%

% of portfolio

1.1%

Previous 0.84%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$163.84 - $199.33 $28,180 - $34,284	-172 Reduced 0.08%	226,796 $44.8 Million
Q2 2024 Aug 14, 2024	SELL	$154.79 - $180.76 $346,110 - $404,179	-2,236 Reduced 0.98%	226,968 $38.9 Million
Q1 2024 May 15, 2024	SELL	$159.82 - $182.1 $2.66 Million - $3.03 Million	-16,646 Reduced 6.77%	229,204 $41.7 Million
Q4 2023 Feb 06, 2024	SELL	$137.6 - $154.97 $5.97 Million - $6.73 Million	-43,417 Reduced 15.01%	245,850 $38.1 Million
Q3 2023 Nov 02, 2023	SELL	$133.59 - $154.65 $53,836 - $62,323	-403 Reduced 0.14%	289,267 $43.1 Million
Q2 2023 Aug 01, 2023	BUY	$132.51 - $164.9 $38.4 Million - $47.8 Million	289,670 New	289,670 $39 Million
Q1 2023 May 09, 2023	BUY	$144.61 - $166.54 $2.57 Million - $2.96 Million	17,749 Added 5.74%	327,144 $52.1 Million
Q4 2022 Feb 02, 2023	SELL	$138.31 - $165.87 $100,689 - $120,753	-728 Reduced 0.23%	309,395 $50 Million
Q3 2022 Nov 08, 2022	SELL	$134.21 - $153.93 $404,911 - $464,406	-3,017 Reduced 0.96%	310,123 $41.6 Million
Q2 2022 Jul 29, 2022	SELL	$137.62 - $174.96 $47.1 Million - $59.9 Million	-342,605 Closed	0 $0
Q1 2022 Apr 27, 2022	SELL	$131.98 - $163.75 $639,311 - $793,205	-4,844 Reduced 1.39%	342,605 $55.5 Million
Q4 2021 Feb 03, 2022	SELL	$107.43 - $135.93 $1.8 Million - $2.28 Million	-16,778 Reduced 4.61%	347,449 $47 Million
Q3 2021 Nov 05, 2021	SELL	$106.4 - $120.78 $213,970 - $242,888	-2,011 Reduced 0.55%	364,227 $39.3 Million
Q2 2021 Aug 05, 2021	BUY	$105.21 - $117.21 $3.83 Million - $4.27 Million	36,396 Added 11.03%	366,238 $41.3 Million
Q1 2021 May 06, 2021	SELL	$102.3 - $112.62 $98,617 - $108,565	-964 Reduced 0.29%	329,842 $35.7 Million
Q4 2020 Feb 05, 2021	SELL	$80.49 - $108.67 $9.35 Million - $12.6 Million	-116,135 Reduced 25.98%	330,806 $35.4 Million
Q3 2020 Nov 06, 2020	BUY	$85.91 - $100.83 $12.3 Million - $14.4 Million	142,774 Added 46.94%	446,941 $39.1 Million
Q2 2020 Aug 06, 2020	SELL	$73.37 - $98.18 $1.97 Million - $2.64 Million	-26,895 Reduced 8.12%	304,167 $29.9 Million
Q1 2020 May 07, 2020	SELL	$64.5 - $97.79 $2.66 Million - $4.04 Million	-41,303 Reduced 11.09%	331,062 $25.2 Million
Q4 2019 Jan 30, 2020	BUY	$72.13 - $90.25 $2.05 Million - $2.57 Million	28,434 Added 8.27%	372,365 $33 Million
Q3 2019 Nov 12, 2019	SELL	$62.98 - $75.72 $42,700 - $51,338	-678 Reduced 0.2%	343,931 $26 Million
Q2 2019 Aug 06, 2019	BUY	$65.7 - $83.98 $3.02 Million - $3.87 Million	46,033 Added 15.42%	344,609 $25.1 Million
Q1 2019 May 08, 2019	BUY	$77.14 - $90.79 $5.28 Million - $6.22 Million	68,494 Added 29.77%	298,576 $24.1 Million
Q4 2018 Feb 12, 2019	BUY	$77.85 - $96.01 $1.01 Million - $1.25 Million	12,986 Added 5.98%	230,082 $21.2 Million
Q3 2018 Nov 09, 2018	SELL	$88.91 - $98.84 $13.9 Million - $15.5 Million	-156,685 Reduced 41.92%	217,096 $20.5 Million
Q2 2018 Aug 08, 2018	SELL	$89.78 - $106.23 $366,930 - $434,162	-4,087 Reduced 1.08%	373,781 $34.6 Million
Q1 2018 May 10, 2018	BUY	$92.01 - $123.21 $13.4 Million - $17.9 Million	145,528 Added 62.64%	377,868 $35.8 Million
Q4 2017 Feb 02, 2018	SELL	$89.56 - $98.21 $365,404 - $400,696	-4,080 Reduced 1.73%	232,340 $22.5 Million
Q3 2017 Nov 06, 2017	BUY	$69.85 - $89.22 $15.5 Million - $19.8 Million	222,036 Added 1543.63%	236,420 $21 Million
Q2 2017 Aug 09, 2017	BUY	N/A	14,384	14,384 $1.04 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Todd Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Todd Asset Management LLC with notifications on news.

Account

Todd Asset Management LLC Abb Vie Inc. Transaction History